Leukemic conversion involving RAS mutations of type 1 CALR-mutated primary myelofibrosis in a patient treated for HCV cirrhosis: a case report

Overview of attention for article published in Frontiers in oncology, September 2023

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (52nd percentile)
High Attention Score compared to outputs of the same age and source (86th percentile)

Mentioned by

twitter: 4 X users

Readers on

mendeley: 4 Mendeley

Summary X

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 19,660 followers.

Leukemic conversion involving RAS mutations of type 1 CALR-mutated primary myelofibrosis in a patient treated for HCV cirrhosis: a case report https://t.co/boW9hEvQfv

16 Oct 2023

Reply Repost Favourite

Leukemic conversion involving RAS mutations of type 1 CALR-mutated primary myelofibrosis in a patient treated for HCV cirrhosis: a case report https://t.co/qPlng5X2Pd

16 Oct 2023

Reply Repost Favourite

RT @FrontOncology: New research: Leukemic conversion involving RAS mutations of type 1 CALR-mutated primary myelofibrosis in a patient trea…

03 Oct 2023

Reply Repost Favourite

New research: Leukemic conversion involving RAS mutations of type 1 CALR-mutated primary myelofibrosis in a patient treated for HCV cirrhosis: a case report: Somatic frameshift mutations in exon 9 of calreticulin (CALR) gene are recognized as… #oncology ht

03 Oct 2023

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.